CheckMate 214 - a winning combination?

Nat Rev Clin Oncol. 2018 Jun;15(6):343. doi: 10.1038/s41571-018-0020-4.
No abstract available

Publication types

  • Comment

MeSH terms

  • Carcinoma, Renal Cell*
  • Humans
  • Ipilimumab
  • Kidney Neoplasms*
  • Nivolumab
  • Sunitinib

Substances

  • Ipilimumab
  • Nivolumab
  • Sunitinib